ProductQuiz LS

2
IP & Science Product Portfolio Life Sciences Product Quiz Over the course of this week (26 – 30 Nov 2012) a total of 9 questions (3 on Mon, Wed & Fri) will be posted relating to the information that we have in our products. You will need to login to the products listed and search for the answers. The featured products will be Cortellis CI, Cortellis RI, Integrity and Newport. THE WINNERS: The answers to all 9 questions must be submitted by the end of the day on Monday 3 rd Dec to Alex Acheson . All correct & complete entries will be added to a hat and 5 winners will be drawn! THE PRIZE: A voucher worth £10 (or equivalent, depending on your country). MONDAY: CORTELLIS (both Competitive Intelligence & Regulatory Intelligence) 1. GlaxoSmithKline has a drug in phase II development for Alzheimer's disease and atherosclerosis. What is the name of this drug? 2. A presentation from Piramal was covered in the second overnight report from September's ICAAC conference. Find the corresponding drug record and tell us the date captured in Cortellis that discovery research began? 3. In the Regulatory Intelligence area, search for Regulatory Intelligence Reports published in March 2012 and filter region to those covering Australia – what is the name of this document? WEDNESDAY: INTEGRITY 1. A phase III study of Alirocumab in acute coronary syndrome recently got underway. What is the name of this trial?

description

Life Sciencrs

Transcript of ProductQuiz LS

Page 1: ProductQuiz LS

IP & Science Product PortfolioLife Sciences Product Quiz

Over the course of this week (26 – 30 Nov 2012) a total of 9 questions (3 on Mon, Wed & Fri) will be posted relating to the information that we have in our products. You will need to login to the products listed and search for the answers.The featured products will be Cortellis CI, Cortellis RI, Integrity and Newport.

THE WINNERS: The answers to all 9 questions must be submitted by the end of the day on Monday 3rd Dec to Alex Acheson. All correct & complete entries will be added to a hat and 5 winners will be drawn!

THE PRIZE: A voucher worth £10 (or equivalent, depending on your country).

MONDAY: CORTELLIS (both Competitive Intelligence & Regulatory Intelligence)

1. GlaxoSmithKline has a drug in phase II development for Alzheimer's disease and atherosclerosis. What is the name of this drug?

2. A presentation from Piramal was covered in the second overnight report from September's ICAAC conference. Find the corresponding drug record and tell us the date captured in Cortellis that discovery research began?

3. In the Regulatory Intelligence area, search for Regulatory Intelligence Reports published in March 2012 and filter region to those covering Australia – what is the name of this document?

WEDNESDAY: INTEGRITY

1. A phase III study of Alirocumab in acute coronary syndrome recently got underway. What is the name of this trial?

2. Search the Experimental Models knowledge area for a model where the species is chicken and the indication is cancer. What is the Study Type for the model?

3. Find the Acute Radiation Syndrome (ARS) Targetscape (this is in the Targets and Pathways knowledge area, the only Targetscape under the Poisoning condition). List the 3 intracellular effects of ARS shown in this Targetscape?

FRIDAY: NEWPORT

1. How many active Drug Master Files in the US does Bayer AG have? (Hint: check the Manufacturing Profile table!)

Page 2: ProductQuiz LS

2. What were the rest of world sales of pregabalin in the 12 months ending June 2012?

3. Veropharm hold one New use type patent, which active ingredient is it for?